Results 111 to 120 of about 32,848 (294)

Hyperthermic Intraperitoneal Chemotherapy [PDF]

, 2020
Yuranga Weerakkody, Craig Hacking, Thomas Lausen   +2 more
openaire   +2 more sources

Successful Implementation of HITOC and HIPEC in the Management of Advanced Ovarian Carcinoma with Pleural and Peritoneal Carcinomatosis

Diagnostics
This case report details the application and outcomes of a novel therapeutic approach involving hyperthermic intraperitoneal chemotherapy (HIPEC) and hyperthermic intrathoracic chemotherapy (HITOC) in a single patient diagnosed with advanced ovarian ...
Bogdan Moldovan, Codin Theodor Saon, Iris-Iuliana Adam, Radu-Mihai Pisica, Vlad Teodor Silaghi, Vlad Untaru, Doly Stoica, Madalina Crisan, Andreea Popianas, Florentina Pescaru, Adriana Zolog, Liliana Vecerzan   +11 more
doaj   +1 more source

Morbidity and Mortality Rates Following Cytoreductive Surgery Combined With Hyperthermic Intraperitoneal Chemotherapy Compared With Other High-Risk Surgical Oncology Procedures

JAMA Network Open, 2019
Key Points Question What are the morbidity and mortality of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) compared with other major oncologic surgical procedures?
J. Foster, R. Sleightholm, Asish Patel, V. Shostrom, B. Hall, B. Neilsen, D. Bartlett, Lynette M. Smith   +7 more
semanticscholar   +1 more source

Worldwide barriers of optimal surgical care provision in advanced ovarian cancer

International Journal of Gynecology &Obstetrics, Volume 171, Issue S1, Page 129-137, September 2025.
Abstract Ovarian cancer (OC) remains one of the most challenging gynecological malignancies to cure, despite recent advances in treatment. Disparities in the diagnosis, management, and survival of OC exist worldwide and addressing them remains an ongoing challenge.
Shriya Varghese, Myong Cheol Lim, Robert Armbrust, Rene Pareja, Christina Fotopoulou   +4 more
wiley   +1 more source

Bases and foundations of the treatment of peritoneal carcinomatosis: Review article [PDF]

, 2016
Peritoneal carcinomatosis refers to a shedding or tumor that spreads to the peritoneal serosa and structures of the abdominal cavity. It is an entity with a poor prognosis.
Barrios Sánchez, P., Castro Mesta, Julio Fernando, González Guerrero, Juan Francisco, Villarreal Cavazos, Gerardo   +3 more
core  

Inguinal Lymph Node Metastasis of a Primary Serous Papillary Carcinoma of the Peritoneum One Year after CRS and HIPEC [PDF]

, 2018
Background: Primary peritoneal serous papillary carcinoma is a rare malignant epithelial tumor which was first described in 1959. Peritoneal serous papillary carcinoma arises from the peritoneal epithelium and originates from a single or multicentric ...
Brandl, Andreas, Feist, Mathilde, Katou, Shadi, Pratschke, Johann, Rau, Beate, Raue, Wieland   +5 more
core   +1 more source

Indigenous way of hyperthermic intraperitoneal chemotherapy

Journal of Peritoneum (and other serosal surfaces), 2020
Introduction: Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a form of highly concentrated, heated chemotherapy that is delivered directly to the abdomen intra-operatively. Currently for peritoneal surface malignancy (PSM), either primary or secondary from gastrointestinal (GI) or gynecologic cancers, cytoreductive surgery (CRS) combined with ...
Rishin Dutta, Soumen Das, Makhan Lal Saha   +2 more
openaire   +1 more source

Cancer of the ovary, fallopian tube, and peritoneum: 2025 update

International Journal of Gynecology &Obstetrics, Volume 171, Issue S1, Page 6-35, September 2025.
Abstract In 2014, FIGO's Committee for Gynecologic Oncology revised the staging of ovarian cancer, incorporating ovarian, fallopian tube, and peritoneal cancer into the same system. Most of these malignancies are high‐grade serous carcinomas (HGSCs).
Malte Renz, Michael Friedlander, Jonathan S. Berek   +2 more
wiley   +1 more source

Occupational safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) [PDF]

, 2017
Background: Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has emerged as a novel method to treat extensive, small volume peritoneal metastases.
Ceelen, Wim, Sessink, Paul, Willaert, Wouter   +2 more
core   +2 more sources

Emerging therapeutic approaches for peritoneal metastases from gastrointestinal cancers

Molecular Therapy: Oncology
Peritoneal metastases from gastrointestinal malignancies present difficult management decisions, with options consisting primarily of systemic chemotherapy or major surgery with or without hyperthermic intraperitoneal chemotherapy.
Aleksandra Sikora, Kevin M. Sullivan, Sean Dineen, Mustafa Raoof, Aleksandra Karolak   +4 more
doaj   +1 more source